The PTEN/PI3K/mTOR pathway is one of the main focuses in cancer discovery because of the frequent dysregulation through the increased expression and/or activation of receptor tyrosine kinases, mutations in pathway components, or loss of negative pathway regulators, such as PTEN [145]. This evidence concerns the gene MTOR and cancer.